Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Chemokine receptor antagonist development.

Garin A, Johnson Z, Hermant A, Beltran F, Ratinaud Y, Michel A, Krohn S, Gaudet M, Carboni S, Ji H, Missotten M, Leger O, Power C, Proudfoot A.

Methods Mol Biol. 2013;1013:67-92. doi: 10.1007/978-1-62703-426-5_6.

PMID:
23625494
2.

CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.

Yu X, Huang Y, Collin-Osdoby P, Osdoby P.

J Bone Miner Res. 2004 Dec;19(12):2065-77. Epub 2004 Sep 20.

PMID:
15537451
3.

Drug discovery targeting the chemokine system--where are we?

Horuk R, Proudfoot AE.

Front Biosci (Elite Ed). 2009 Jun 1;1:209-19. Review.

PMID:
19482638
4.

Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.

Strong AE, Thierry AC, Cousin P, Moulon C, Demotz S.

Eur Cytokine Netw. 2006 Mar;17(1):49-59.

PMID:
16613763
5.

CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.

Gladue RP, Tylaska LA, Brissette WH, Lira PD, Kath JC, Poss CS, Brown MF, Paradis TJ, Conklyn MJ, Ogborne KT, McGlynn MA, Lillie BM, DiRico AP, Mairs EN, McElroy EB, Martin WH, Stock IA, Shepard RM, Showell HJ, Neote K.

J Biol Chem. 2003 Oct 17;278(42):40473-80. Epub 2003 Aug 7.

PMID:
12909630
6.

Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.

Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, McCarley D, Mulkins M, Weatherhead GS, Lapierre JM, Dankwardt J, Morgans D Jr, Wilhelm R, Jarnagin K.

J Biol Chem. 2000 Aug 18;275(33):25562-71.

PMID:
10770925
7.

Identification and characterization of novel antagonists of the CCR3 receptor.

Warrior U, McKeegan EM, Rottinghaus SM, Garcia L, Traphagen L, Grayson G, Komater V, McNally T, Helfrich R, Harris RR, Bell RL, Burns DJ.

J Biomol Screen. 2003 Jun;8(3):324-31.

PMID:
12857386
8.

Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines.

Reckless J, Grainger DJ.

Biochem J. 1999 Jun 15;340 ( Pt 3):803-11.

PMID:
10359667
9.

Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.

Chou CC, Fine JS, Pugliese-Sivo C, Gonsiorek W, Davies L, Deno G, Petro M, Schwarz M, Zavodny PJ, Hipkin RW.

Br J Pharmacol. 2002 Nov;137(5):663-75.

PMID:
12381680
10.

High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).

Wang D, Li Y, Zhang Y, Liu Y, Shi G.

Comb Chem High Throughput Screen. 2012 Mar;15(3):232-41. Review.

PMID:
22221056
11.

Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.

Hatse S, Princen K, Liekens S, Vermeire K, De Clercq E, Schols D.

Cytometry A. 2004 Oct;61(2):178-88.

PMID:
15382150
12.

CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.

Scandella E, Men Y, Legler DF, Gillessen S, Prikler L, Ludewig B, Groettrup M.

Blood. 2004 Mar 1;103(5):1595-601. Epub 2003 Oct 30.

PMID:
14592837
13.

The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production.

Randolph-Habecker JR, Rahill B, Torok-Storb B, Vieira J, Kolattukudy PE, Rovin BH, Sedmak DD.

Cytokine. 2002 Jul 7;19(1):37-46.

PMID:
12200112
14.

Differential expression of chemokines and chemokine receptors during microglial activation and inhibition.

Kremlev SG, Roberts RL, Palmer C.

J Neuroimmunol. 2004 Apr;149(1-2):1-9.

PMID:
15020059
15.

Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.

Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P, Marra F.

J Biol Chem. 2001 Mar 30;276(13):9945-54. Epub 2001 Jan 2.

PMID:
11136732
16.

A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum.

L├╝ttichau HR, Stine J, Boesen TP, Johnsen AH, Chantry D, Gerstoft J, Schwartz TW.

J Exp Med. 2000 Jan 3;191(1):171-80.

PMID:
10620615
17.

A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis.

Morandi F, Ferretti E, Bocca P, Prigione I, Raffaghello L, Pistoia V.

PLoS One. 2010 Jul 23;5(7):e11763. doi: 10.1371/journal.pone.0011763.

PMID:
20668702
18.

Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.

Clark-Lewis I, Mattioli I, Gong JH, Loetscher P.

J Biol Chem. 2003 Jan 3;278(1):289-95. Epub 2002 Nov 1.

PMID:
12417585
19.

Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.

Martin E, Mukherjee P, Sullivan D, Jansen J.

J Chem Inf Model. 2011 Aug 22;51(8):1942-56. doi: 10.1021/ci1005004. Epub 2011 Jul 19.

PMID:
21667971
20.

Optimization of CCR4 antagonists: side-chain exploration.

Purandare AV, Wan H, Gao A, Somerville J, Burke C, Vaccaro W, Yang X, McIntyre KW, Poss MA.

Bioorg Med Chem Lett. 2006 Jan 1;16(1):204-7. Epub 2005 Oct 19.

PMID:
16236499

Supplemental Content

Support Center